Zodwa Dlamini – författare

This book explores the relationship between the gut microbiome and cancer, illuminating various facets from fundamental roles to personalized therapies. It provides a comprehensive overview of the impact of the gut microbiome on cancer development, offering potential for innovative diagnostic and treatment approaches.

Towards the end, the book investigates the role of the gut microbiome in pediatric cancer and provides an outlook on the future challenges, technological advancements, and ethical considerations of gut microbiome research in the context of personalized cancer therapies. This book is intended for cancer researchers, medical oncologists, clinicians, pharmacologists, translational investigators, and medical students.

This book explores the relationship between the gut microbiome and cancer, illuminating various facets from fundamental roles to personalized therapies. It provides a comprehensive overview of the impact of the gut microbiome on cancer development, offering potential for innovative diagnostic and treatment approaches.

Towards the end, the book investigates the role of the gut microbiome in pediatric cancer and provides an outlook on the future challenges, technological advancements, and ethical considerations of gut microbiome research in the context of personalized cancer therapies. This book is intended for cancer researchers, medical oncologists, clinicians, pharmacologists, translational investigators, and medical students.

This book delves into the complexities of melanoma, offering an in-depth examination of the disease alongside the latest advancements in diagnosis and treatment. The initial chapter provides a comprehensive overview of melanoma, covering its fundamentals and introducing the latest technologies shaping the understanding of the disease. The book introduces advanced molecular diagnostics in identifying targetable mutations and tailoring therapies for personalized and effective melanoma treatment. Additionally, it investigates the role of artificial intelligence in melanoma diagnostics and the advancements in imaging technologies for the monitoring and assessment of melanoma. It also reviews novel, innovative immunotherapeutic approaches designed to enhance the body''s immune response against melanoma cells. Further, the book delves into the development and application of targeted therapies and nanomedicine in treating melanoma. A dedicated chapter highlights the advantages of a multi-omics approach, integrating genomic, proteomic, and other omics data to achieve a holistic understanding of melanoma. Toward the end, the book examines the potential of combination therapies to improve treatment outcomes in melanoma. The book is a valuable source for cancer researchers, medical oncologists, and clinicians.

Key Features

This book delves into the complexities of melanoma, offering an in-depth examination of the disease alongside the latest advancements in diagnosis and treatment. The initial chapter provides a comprehensive overview of melanoma, covering its fundamentals and introducing the latest technologies shaping the understanding of the disease. The book introduces advanced molecular diagnostics in identifying targetable mutations and tailoring therapies for personalized and effective melanoma treatment. Additionally, it investigates the role of artificial intelligence in melanoma diagnostics and the advancements in imaging technologies for the monitoring and assessment of melanoma. It also reviews novel, innovative immunotherapeutic approaches designed to enhance the body''s immune response against melanoma cells. Further, the book delves into the development and application of targeted therapies and nanomedicine in treating melanoma. A dedicated chapter highlights the advantages of a multi-omics approach, integrating genomic, proteomic, and other omics data to achieve a holistic understanding of melanoma. Toward the end, the book examines the potential of combination therapies to improve treatment outcomes in melanoma. The book is a valuable source for cancer researchers, medical oncologists, and clinicians.

Key Features

The book provides a comprehensive examination of pancreatic cancer, integrating global insights with an African-focused perspective. Understanding Pancreatic Cancer: Global Strategies and African Perspectives is structured into five parts, each addressing key aspects of the disease, from epidemiology to future innovations in care. Part I (Chapters 1 and 2) explores the global and African contexts, highlighting disparities in prevalence, diagnosis, and healthcare infrastructure. Part II (Chapter 3) delves into the biological and molecular mechanisms of pancreatic cancer, including genetic mutations and emerging therapeutic targets. Part III (Chapters 4 and 5) focuses on precision medicine and early detection, discussing advances such as artificial intelligence (AI) and biomarker-driven approaches. Part IV (Chapters 6-8) covers treatment strategies, from conventional therapies to novel interventions like immunotherapy and targeted treatments. Finally, Part V (Chapters 9-11) emphasizes the importance of advocacy, research, and policy reforms, outlining strategies for improving patient outcomes and shaping the future of pancreatic cancer care.

By bridging scientific advancements with real-world challenges, this book serves as an essential resource for researchers, clinicians, and policymakers working to enhance pancreatic cancer diagnosis, treatment, and prevention—both in Africa and globally.

Key Features

The book provides a comprehensive examination of pancreatic cancer, integrating global insights with an African-focused perspective. Understanding Pancreatic Cancer: Global Strategies and African Perspectives is structured into five parts, each addressing key aspects of the disease, from epidemiology to future innovations in care. Part I (Chapters 1 and 2) explores the global and African contexts, highlighting disparities in prevalence, diagnosis, and healthcare infrastructure. Part II (Chapter 3) delves into the biological and molecular mechanisms of pancreatic cancer, including genetic mutations and emerging therapeutic targets. Part III (Chapters 4 and 5) focuses on precision medicine and early detection, discussing advances such as artificial intelligence (AI) and biomarker-driven approaches. Part IV (Chapters 6-8) covers treatment strategies, from conventional therapies to novel interventions like immunotherapy and targeted treatments. Finally, Part V (Chapters 9-11) emphasizes the importance of advocacy, research, and policy reforms, outlining strategies for improving patient outcomes and shaping the future of pancreatic cancer care.

By bridging scientific advancements with real-world challenges, this book serves as an essential resource for researchers, clinicians, and policymakers working to enhance pancreatic cancer diagnosis, treatment, and prevention—both in Africa and globally.

Key Features

This book highlights the use of artificial intelligence (AI), big data and precision oncology for medical decision making in cancer screening, diagnosis, prognosis and treatment. Precision oncology has long been thought of as ideal for the management and treatment of cancer. This strategy promises to revolutionize the treatment, control, and prevention of cancer by tailoring tests, treatments and predictions to specific individuals or population groups. In order to accomplish these goals, vast amounts of patient or population group specific data needs to be integrated and analysed to be able to identify key patterns or features which can be used to define or characterize the disease or the response to the disease in these individuals. These patterns or features can be as varied as molecular patterns or features in medical images. This level of data analysis and integration can only be achieved through the use of AI.

The book is divided into three parts starting with a section on the use of artificial intelligence for screening, diagnosis and monitoring in precision oncology. The second part: Artificial intelligence and Omics in precision oncology, highlights the use of AI and epigenetics, metabolomics, microbiomics in precision oncology. The third part covers artificial intelligence in cancer therapy and its clinical applications. It also highlights the use of AI tools for risk prediction, early detection, diagnosis and accurate prognosis.

This book, written by experts in the field from academia and industry, will appeal to cancer researchers, clinical oncologists, pathologists, medical students, academic teaching staff and medical residents interested in cancer research as well as those specialising as clinical oncologists.

This book analyses the ability of technological advancements to represent, enhance, and empower multidisciplinarity in the context of Society 5.0. and next generation medicine. New technologies allow patients to communicate with medical personnel anytime, anywhere and shape the terrain of healthcare ecosystem at an unprecedented rate. Five main trends become apparent in this process: Hybrid care models combining virtual and in-person services, digitization of healthcare specialties, increased Artificial intelligence (AI) adoption, health systems moving to the cloud and advanced precision medicine.

In its chapters the book dissects the important roles for technologies in areas such as digital twinning, big data, Internet of Things, AI, cyber-physical systems, blockchain technology to lead the healthcare digitalization envisioned in Society 5.0. Throughout the book the authors discuss how to incorporate these new technologies legally, ethically, safely, and securely and in keeping with the highest standards of human rights. It also advocates for the need for careful oversight and mindful allocation of resources and energy for sustainable development.

This book, written by experts in the field from academia and industry, will appeal to researchers, healthcare professionals, policy makers, teachers and students interested in the ways healthcare is reorganized based on digital transformation efforts and the rethinking of care, including technologies.